Whitehawk Therapeutics, Inc. (WHWK)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $177.62M
Last updated: Nov 17, 2026 at 4:11 PM ET
Whitehawk Therapeutics, Inc. (WHWK) Statistics
Whitehawk Therapeutics (WHWK) has a market cap of $177.62M and an enterprise value of $108.64M. Its share count is up 35.64% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 38.83% below the market cap, as cash exceeds debt.
| Market Cap | $177.62M |
|---|---|
| Enterprise Value | $108.64M |
| Latest price (Nov 17, 2026) | $3.08 |
Key Dates
The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 10, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is up 43.93% over 52 weeks and trades 11.49% below its 50-day average.
| Beta (1Y) | 1.49 |
|---|---|
| 52-Week Change | +43.93% |
| 1-Month Change | +2.33% |
| 3-Month Change | -36.76% |
| 6-Month Change | -24.32% |
| 5-Year Change | -88.00% |
| Total Return (1Y) | +43.93% |
| Total Return (3Y CAGR) | -13.20% |
| Total Return (5Y CAGR) | -33.40% |
| Return vs SPY (1Y) | +32.37% |
| Max Drawdown (1Y) | -43.33% |
| Max Drawdown (3Y) | -75.60% |
| Sharpe Ratio (1Y) | 0.54 |
| Correlation with SPY (1Y) | 0.30 |
| 50-Day Average | $3.48 |
| 200-Day Average | $3.86 |
| 52-Week Range | $1.97 to $5.50 |
| RSI (14 Days) | 43.8 |
| Average Volume (20 Days) | 377.12K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 16.47x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 16.47x |
|---|---|
| Quick Ratio | 16.47x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -51.05% over the last 12 months, against a 5-year average of -63.58%.
| Return on Equity (ROE) | -51.05% |
|---|---|
| Return on Assets (ROA) | -47.96% |
| ROE (5Y Average) | -63.58% |
| ROA (5Y Average) | -51.29% |
| ROIC (5Y Average) | -15.55% |
Scores
WHWK has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$1.00K |
| Operating Income | -$89.46M |
| Pretax Income | -$83.29M |
| Net Income | -$83.29M |
| Reported EPS (TTM) | -$1.09 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 93.94% of the $173.69M in total assets.
| Cash and Equivalents | $68.97M |
|---|---|
| Total Debt | $0 |
| Net Cash | $68.97M |
| Net Cash Per Share | $0.73 |
| Working Capital | $161.53M |
| Shareholder Equity | $163.16M |
| Book Value Per Share | $1.74 |
| Total Assets | $173.69M |
| Total Liabilities | $10.53M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$73.64M |
|---|---|
| FCF Per Share | -$1.29 |
| Depreciation and Amortization | $1.88M |
Trailing 12 months through Sep 30, 2026.
Growth
Revenue fell 22.27% a year over 3 years.
| Revenue Growth (3Y CAGR) | -22.27% |
|---|---|
| Revenue Growth (5Y CAGR) | -13.29% |
| Book Value Per Share Growth (2Y CAGR) | -28.95% |
| Tangible Book Per Share Growth (2Y CAGR) | -28.95% |
Dividends and Yields
WHWK does not pay a dividend.
| Buyback Yield | -28.27% |
|---|---|
| Shareholder Yield | -28.27% |
Stock Splits
The last split was a 1-for-15 reverse split on Aug 27, 2021.
| Last Split Date | Aug 27, 2021 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:15 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About WHWK
What is WHWK's market cap?
Whitehawk Therapeutics has a market cap of $177.62M. Its enterprise value, which adds debt and subtracts cash, is $108.64M.
How many shares of WHWK are outstanding?
Whitehawk Therapeutics has 93.87M shares outstanding. The count is up 35.64% from a year earlier.
Does WHWK pay a dividend?
No. Whitehawk Therapeutics does not pay a dividend.
How much debt does WHWK have?
Whitehawk Therapeutics has $0 of total debt and $68.97M of cash and equivalents, a net cash position of $68.97M.
WHWK pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors